Compare WVE & TCBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WVE | TCBX |
|---|---|---|
| Founded | 2012 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 744.8M | 751.0M |
| IPO Year | 2015 | 2021 |
| Metric | WVE | TCBX |
|---|---|---|
| Price | $3.88 | $42.87 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 18 | 6 |
| Target Price | $18.53 | ★ $48.33 |
| AVG Volume (30 Days) | ★ 2.8M | 80.7K |
| Earning Date | 11-09-2026 | 10-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 36.33 |
| EPS | N/A | ★ 1.97 |
| Revenue | ★ $3,704,000.00 | N/A |
| Revenue This Year | $20.53 | $23.51 |
| Revenue Next Year | N/A | $9.40 |
| P/E Ratio | ★ N/A | $21.55 |
| Revenue Growth | ★ 149.43 | N/A |
| 52 Week Low | $3.56 | $35.73 |
| 52 Week High | $21.73 | $46.36 |
| Indicator | WVE | TCBX |
|---|---|---|
| Relative Strength Index (RSI) | 36.57 | 34.88 |
| Support Level | N/A | $36.60 |
| Resistance Level | $6.33 | $43.20 |
| Average True Range (ATR) | 0.21 | 1.01 |
| MACD | -0.02 | -0.25 |
| Stochastic Oscillator | 38.99 | 15.61 |
WAVE Life Sciences Inc is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
Third Coast Bancshares Inc is a bank holding company. It focuses on providing commercial banking solutions to small and medium-sized businesses and professionals with operations in its markets. The bank operates twenty branches in the Greater Houston, Dallas-Fort Worth, and Austin-San Antonio markets, one branch in Ballinger, Texas, and one branch in Detroit, Texas. The company operates through one segment, community banking, It generates the majority of its revenue from interest on loans, customer service, and loan fees.